Back

Dapagliflozin decreases atherosclerotic plaque instability via regulating macrophage pyroptosis

27 August 2023 (14:15 - 15:00)
Organised by: Logo
Congress Presentation Part of: Therapeutic strategies to combat vascular disease Atherosclerosis, Cerebrovascular Diseases, Aneurysm, Restenosis ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Lili Xu

Zhongshan Hospital Fudan University, Shanghai (China)

7 More presentations in this session

Presentation thumbnail
Atheroprotective CD40-TRAF6 inhibitors: translational pipeline towards a clinical application
Doctor V. Bazioti (Munich, DE)
Abstract Slides Video
Presentation thumbnail
Characterization of AT-02, a pan-amyloid-binding peptide fusion immunoglobulin with high binding potency, complement activation, and immune cell stimulation
Professor J. Wall (Knoxville, US)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin downregulates G protein-coupled receptor Kinase-2 and upregulates regulator of g protein signaling-4 in adrenals to exert sympatholysis in heart failure
Associate Professor A. Lymperopoulos (Fort Lauderdale, US)
Abstract Slides Video
Presentation thumbnail
Effective cardiac mRNA delivery using lipid nanoparticles
Ms M. Labonia (Utrecht, NL)
Abstract Slides Video
Presentation thumbnail
HS135, a novel activin and GDF trap, is highly efficacious in preclinical models of pulmonary hypertension and obesity-associated heart failure with preserved ejection fraction
Doctor J. Schoelermann (Montreal, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Therapeutic strategies to combat vascular disease

The Event

Event poster

ESC Congress 2023

27 August 2023 14:15 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources